Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

BDI Pharma

BDI Pharma?uq=w9if130k
1995 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Distributor of specialty bio-pharmaceutical products intended to meet the distribution and support needs through customer-centric approach. The company's specialty bio-pharmaceutical products include plasma related pharmaceuticals, ivig infusion therapy, hemophilia factors, albumin and hyper-immunes and other specialty injectables, enabling manufacturers, healthcare providers and patients to get a wide range of critical care pharmaceutical at crucial times.

Formerly Known As
Blood Diagnostics
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Other Industries
Distributors/Wholesale (B2C)
Parent Company
Primary Office
  • 120 Research Drive
  • Columbia, SC 29203
  • United States

+1 (800) 000-0000

BDI Pharma Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore BDI Pharma‘s full profile, request access.

Request full access to PitchBook

BDI Pharma Executive Team (3)

Name Title Board
Seat
Contact
Info
Edward Stiefel Jr. Co-Founder and Co-President
Richard Gaton Co-Founder and Co-President
Rick Schindewolf Chief Financial Officer